|Return to Canadian Foundation for Drug Policy Home Page|
The government statement concerning Bill C-2, the Respect for Communities Act, gives the government's explanation of the purpose and effect of the Bill:The government information (remember, this is information provided by government casting the legislation in the most favourable light) provided when the predecessor Bill (C-65) was introduced in June 2013 can be found here: English Français
On 17 October 2013, the Minister of Health introduced Bill C-2, An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act), in the House of Commons and it was given first reading.
Currently, under section 56 of the Controlled Drugs and Substances Act, the Minister has the authority to grant an exemption to undertake activities using controlled substances for a medical or scientific purpose, or in the public interest. Approximately 10,000 section 56 exemption applications are received every year, most of which are for routine activities using controlled substances from licit sources, including clinical trials, methadone treatment and university research.
Bill C-2 amends the Controlled Drugs and Substances Act to, among other things,
• create a separate exemption regime for activities involving the use of a controlled substance or precursor that is obtained in a manner not authorized under this Act;
• specify the purposes for which an exemption may be granted for those activities; and
• set out the information that must be submitted to the Minister of Health before the Minister may consider an application for an exemption in relation to a supervised consumption site.